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Summary
We attempted to answer two central questions about epigenetic silencing of the tumor suppressor gene p16INK4a in this
study: (1) whether the maintenance of associated histone modifications is dependent on DNA methylation and (2) whether
such histone modifications can occur prior to DNA methylation. By coupling chromatin immunoprecipitation with gene
targeting and the analysis of specific alleles, we found that elimination of DNA methylation from a p16INK4a allele resulted
in profound changes in surrounding histones. After continued passage of such cells, methylation of histone H3 lysine-9
occurred in conjunction with re-silencing in the absence of DNA methylation. These results have important implications
for understanding the biochemical events underlying the silencing of tumor suppressor genes and the resultant growth
suppression.
Introduction pressor gene silencing, histone modifications, and DNA methyl-
ation.
A variety of tumor suppressor genes have been shown to be
silenced in human cancers (Jones and Baylin, 2002). In virtually Results and discussion
all cases, the silencing is accompanied by DNA hypermethyla-
tion of the promoters of these genes, and DNA methylation has Colorectal cancer cells in which the DNMT1 and DNMT3B genes
are disrupted (termed DKO for double knockout) were noted tooften been interpreted to be causally involved in the silencing.
DNA methylation is also associated with silencing of genes on grow very slowly compared to parental cells. With continued
passage of these cells, the cells’ growth rate increased (Figurethe inactive X chromosome. However, studies have shown that
DNA methylation occurs only after X chromosome inactivation, 1A). To investigate the basis for the growth change, we first
analyzed the expression of the p16INK4a gene. In parental cells,excluding DNA methylation as the proximate cause (Heard et
al., 1997; Migeon, 1994). Analogous results have not been de- one allele of p16INK4a is wild-type (wt) and silenced while the
other harbors a truncating frameshift mutation and is expressedscribed for tumor suppressor genes on the autosomes.
A recently developed experimental system has given us (Myohanen et al., 1998). When DNA methylation is erased
through disruption of DNMT1 and DNMT3B, silencing of the wtthe opportunity to evaluate the biochemical events underlying
silencing in a temporal fashion. When both the DNA Methyltrans- allele is eliminated (Rhee et al., 2002 and Figure 1B, passage
5 cells). By passage 22, when the growth rate has increasedferase 1 (DNMT1) and DNA Methyltransferase 3B (DNMT3B)
genes are disrupted through gene targeting, virtually all DNA (Figure 1A), the wt allele is again completely silenced (Figure
1B). Evaluation of the DNA methylation status of the p16INK4amethyltransferase activity and DNA methylation are eliminated
(Rhee et al., 2002). This situation is akin to that occurring in gene by real time methylation-specific PCR (MSP) showed dis-
cordance between expression and DNA methylation at passagedeveloping germ cells, wherein DNA methylation is erased, per-
mitting parental imprinting (Razin et al., 1984; Reik et al., 2001). 22. Though the wt allele of p16INK4a was silenced and methylated
in parental HCT116 cells, no DNA methylation of the silencedThis system has given us a unique opportunity to address partic-
ular questions regarding the relationship between tumor sup- wt allele was observed in the DKO cells at passage 22 (Figure
S I G N I F I C A N C E
The mechanisms underlying epigenetic silencing have been extensively investigated in various non-mammalian systems, but very
little is known about this process in tumor suppressor genes in cancer cells. Our data show that the maintenance of epigenetic
silencing and of associated histone modifications is dependent on DNA methylation. Because we used a genetic rather than
pharmacologic approach to remove DNA methyl groups, the data leading to this conclusion were unambiguous. Moreover, we
found that histone modifications associated with silencing of a tumor suppressor gene can occur independently of DNA methylation.
These studies demonstrate similarities between the processes of epigenetic silencing of tumor suppressor genes and X inactivation
and suggest that DNA methylation serves to “lock in” rather than initiate silencing.
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Figure 1. Changes in growth rate and p16INK4A silencing in DKO cells after serial passage in culture
A: Growth curves of parental HCT116 and DKO cells at passages 5, 22, and 87. The points and bars represent the average and standard error, respectively,
determined from triplicate measurements.
B: Sequence of genomic DNA and cDNA of exon 1 of the p16INK4A gene from DKO cells at passages 5 and p22. Arrows point to the frameshift mutation in
the mutant allele.
C: Quantitative assessment of the DNA methylation status of p16INK4A by real time methylation-specific PCR of parental HCT116 and DKO cells at the
indicated passage (p) number.
D: Genomic bisulfite sequencing of the p16INK4A 5CpG island. A portion of the autoradiograph is shown. Arrows point to ten C residues that were unmethylated
and converted to thymidines in passage 5 DKO cells, wherein p16INK4A was active, but also in passage 22 DKO cells, wherein p16INK4A was silenced. The
control sequencing lanes were derived from RKO cells, wherein both alleles of the p16INK4A gene are methylated and inactive.
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1C). By passage 87, the wt allele had become methylated. Thus,
silencing preceded DNA methylation. These changes in growth,
DNA methylation, and gene silencing were observed in each of
three independent DKO clones.
The MSP assay measures methylation at CpG sites shown
previously to be invariably associated with silencing of the
p16INK4a gene (Herman et al., 1996). To ensure that no DNA
methylation occurred elsewhere in this region of the gene, we
preformed pooled genomic bisulfite sequencing. These studies
revealed the absence of methylation at all 20 CpG sites analyzed
at passage 22, at which time the p16INK4a gene had already been
silenced (Figure 1D). The 338 bp region analyzed extended from
108 nucleotides upstream of the translation start site to 230
nucleotides downstream and included the most CpG-rich region
of the CpG island associated with methylation of the p16INK4a
gene (Herman et al., 1996).
To determine whether re-silencing of p16INK4a was associated
with modifications of histones, we performed chromatin immu-
noprecipitation (ChIP) with cells at various passages. By com-
paring the relative levels of wt and mutant p16INK4a alleles in the
immunoprecipitates, we could analyze chromatin modifications
associated with silencing of the wt allele in a highly specific and
quantitative manner. Immunoprecipitated DNA was used as a
template for PCR, and the wt allele was discriminated from the
mutant by virtue of a 1 bp insertion in the latter. One of the
most important covalent modifications of chromatin proteins
involves methylation at lysine 9 of histone H3 (H3-K9), observed
in all eukaryotes studied to date (Bannister et al., 2001; Gendrel
et al., 2002; Lachner et al., 2001; Nakayama et al., 2001; Noma et
al., 2001; Volpe et al., 2002). In parental HCT116 cells, chromatin
immunoprecipitation with an antibody recognizing this residue
showed that the chromatin containing the wt allele of p16INK4a
was methylated at H3-K9, but that the chromatin containing the
mutant allele was unmethylated (Figure 2). Erasure of the DNA
methylation through disruption of the DNMT1 and DNMT3B
genes led to removal of the histone H3-K9 methylation from
the wt allele (Figure 2, passage 5). By passage 22, however, the
chromatin containing the wt allele had become re-methylated at
H3-K9 while the mutant allele remained unmethylated.
Histone acetylation was also changed upon disruption of
Figure 2. Chromatin immunoprecipitation of the p16INK4A geneDNA methylation. In parental cells, the mutant p16INK4a allele was
HCT116 and DKO cells at passages 5, 22, and 87 were subjected to ChIPacetylated to a greater extent than the silenced wt allele. After
analysis. Fluorescently labeled PCR products from the immunoprecipitateserasing DNA methylation, histone H4 acetylation of the wt allele
were separated by capillary electrophoresis to discriminate the wild-type
reappeared, likely reflecting the absence of deacetylase activity from the mutant allele. The antibodies used for ChIP were made against
(Figure 2, passage 5). The parental pattern of histone H4 acetyla- dimethyl-Histone H3-K9 (H3-CH3-K9 Ab) and acetyl-Histone H4 (Ac-H4 Ab).
The “Control” sample represents equivalent PCR products generated fromtion was not fully restored until very late passages (Figure 2,
immunoprecipitates in which no antibody was included.passage 87). Thus gene silencing occurred in conjunction with
histone H3-K9 methylation and well before histone H4 deacetyla-
tion of the chromatin or DNA methylation of the packaged DNA.
We next sought to test whether the silencing of the wt
tation of targeting are shown in Figures 3A and 3B, respectively.p16INK4a allele was not only associated with enhanced growth
Two triple knockout (TKO) clones with the wt p16INK4a allele plusof the subclones, but was essential for such growth. To perform
both DNMT1 alleles and both DNMT3B alleles disrupted (calledthis test in a rigorous manner, we disrupted the wt p16INK4a
“TKOmut/” clones) were generated and compared to a cloneallele through targeted homologous recombination prior to fully
generated analogously except that the mutant p16INK4a alleleerasing methylation by disrupting the DNMT1 and DNMT3B
was disrupted (“TKOwt/”). As expected, the TKOwt/ clones re-genes (Rhee et al., 2002). Exon 1 of p16INK4a was targeted for
expressed the wt p16INK4a allele following the loss of DNA methyl-deletion, leaving the p14ARF gene, which shares exon 2 with
ation (data not shown). Genomic DNA methylation was erasedp16INK4a, unaltered. p14ARF also contains one mutant and one
in all clones, regardless of which p16INK4a allele was targetedwild-type allele, which were both expressed in the parental
(Figure 3C). However, there was a distinct difference in growthHCT116 cells as well as all derivatives employed in this study
(data not shown). The p16INK4a disruption strategy and documen- rate of the TKOwt/ cells compared to the TKOmut/ cells (Figure
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Figure 3. Targeted disruption of the p16INK4A gene increases the growth rate of HCT116 cells in the absence of genomic DNA methylation
A: Schematic representation of the targeting constructs and the p16INK4A locus before and after gene disruption. P, SV40 promoter; pA, polyadenylation
site; black triangles correspond to loxP sites; and exons are indicated by Roman numerals.
B: Genomic sequence analysis of the p16INK4A targeted region, demonstrating deletion of the wild-type and mutant alleles in TKOmut/ and TKO wt/ clones,
respectively.
C: HPLC analysis of genomic DNA methylation in HCT116 cells and TKO cells.
D: Growth curves of DKO passage 5 cells and TKO passage 3 cells analyzed as described in Figure 1A.
3D). The TKOwt/ cells grew at a very slow rate, similar to that methylation, but not with changes in histone H4 acetylation.
Only after the H3-K9 methylation associated with gene silencingof early passages of DKO cells (Figure 3D). In contrast, The
TKOmut/ clones grew much faster, approximately as fast as was replaced did other epigenetic changes come about. These
results suggest that DNA methylation and H4 deacetylationpassage 22 of the DKO cells wherein the wt p16INK4a allele was
re-silenced (compare Figure 1A with Figure 3D). serve to lock chromatin in a specific repressed state that was
originally initiated by the methylation of histone H3-K9, as de-These results have several implications. First, they prove
that the growth rate of cancer cells can depend on silencing of a picted in the model presented in Figure 4.
Certain caveats to this model should be pointed out. Thespecific tumor suppressor gene due to epigenetic modifications.
This conclusion was suggested previously, but the relative im- fact that DNA methylation is required both to maintain gene
silencing and to maintain the methylation signature of silencedportance of p16INK4a could not be determined or distinguished
from the silencing of other growth-controlling genes. By dis- chromatin should be applicable to many naturally occurring
cancers, as the conclusions rest on removing DNA methylrupting a specific allele of p16INK4a, we could show that p16INK4a
was responsible for approximately half of the growth rate de- groups through genetic means from tumor cells that have intact
methyltransferase genes. Indeed it has been shown that silenc-crease achieved by erasure of all DNA methylation. The other
half was presumably due to changes in expression of other ing and DNA methylation of p16INK4a are very common occur-
rences in cancer cells of diverse types (Jones and Baylin, 2002).growth-controlling genes that are dependent on epigenetic si-
lencing. Re-silencing of p16INK4a, however, occurred in the near absence
of methyltransferase activity, an experimentally contrived situa-Second, and most importantly, our data show not only that
DNA methylation is required to maintain silencing of the wt tion. Though this experimental approach was required to investi-
gate the timing of the various events studied, it is certainly notp16INK4a gene, but also that erasure of the methylation signature
of DNA leads to histone modifications. Moreover, there ap- physiological. Our experiments demonstrate that histone H3-
K9 methylation can occur in association with gene silencingpeared strong selective pressure for re-silencing of the wt
p16INK4a allele in these cells. This re-silencing was independent and long before DNA methylation. This formally demonstrates
that the enzymatic mechanisms and recognition elements re-of DNA methylation and was associated with histone H3-K9
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Figure 4. Epigenetic control of the wild-type p16INK4A gene
In parental cells, the wt p16INK4a allele is silenced, the DNA is methylated, histone H4 is deacetylated, and histone H3-K9 in surrounding chromatin is methylated.
When DNA methylation is erased by disruption of the DNMT1 and DNMT3B genes, the histone code is altered and the wt allele of p16INK4A is no longer
silenced. With passaging, methylation of histone H3-K9 occurs in conjunction with re-silencing of the wt p16INK4A allele. Many passages later, histone H4
deacetylation and DNA methylation take place, rendering the chromatin similar to that of parental HCT116 cells. Thus maintenance of the histone code
as well as gene silencing are dependent on DNA methylation, but the process of silencing can be initiated in conjunction with histone H3-K9 methylation
in the absence of changes in DNA methylation or histone H4 acetylation.
quired for chromatin modifications are not dependent on prior there is no evident Xist gene for autosomes as there is for X
chromosomes, one wonders how the cell distinguishes the wtDNA methylation. But the timing of these events may be different
in genetically unmanipulated cells. Further research based on from the mutant p16INK4a allele. One hypothesis to explain this
result invokes a molecular mark on the wt allele that is notthe results presented here may allow evaluation of this possibil-
ity in the future. present on the mutant allele (or vice versa). This putative mark
could be a DNA bound protein, a histone modification, or a DNAOur data support the primary importance of histone H3
methylation in gene silencing in general (Bird, 2001; Gendrel et modification not detected in our assays. Arguing against this
hypothesis is the fact that re-silencing took many generations;al., 2002; Goll and Bestor, 2002; Jenuwein and Allis, 2001;
Lachner and Jenuwein, 2002; Li, 2002; Nakayama et al., 2001; at least 30 cell-doublings occurred between the generation of
each DKO clone and passage 5. One would have expected thatNoma et al., 2001; Volpe et al., 2002). Moreover, the epigenetic
events associated with silencing of the p16INK4a suppressor gene a mark would have led to more rapid establishment of silencing,
perhaps even within one generation. Our working hypothesis isobserved in our study have remarkable similarities to those
associated with silencing of the inactive X chromosome (Heard therefore that the silencing is simply stochastic, and that it
occurs randomly, much like mutations but at higher frequency.et al., 2001; Keohane et al., 1996; Mermoud et al., 2002). As
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Buffer (Upstate) and incubated on ice for 10 min. Chromatin was then soni-In the case of the system analyzed here, the remarkable growth
cated to an average length of 1 kb using a Branson Sonifier 250 (Bransonadvantage resulting from the absence of functional p16INK4a ex-
Ultrasonics, Danbury, Connecticut) with microtip at 40% duty cycle. Soni-pression would allow cells with a silenced wt p16INK4a allele to
cated chromatin was the subjected to immunoprecipitation using a protocol
rapidly overtake the population. The epigenetic changes that provided by Upstate. Antibodies used for ChIP were anti-dimethyl-Histone
accompany this silencing then would provide a heritable signal H3 (Lys9) and anti-acetyl-Histone H4 (Upstate).
for its retention in the cell’s progeny. It will be of interest to
Allele-specific ChIP analysisdetermine whether this hypothesis, as well as other features of
To discriminate between the wild-type and mutant p16INK4A alleles, a PCRthe model depicted in Figure 4, applies to the many other genes
based assay was developed. The wild-type p16INK4A allele contains four guani-that are epigenetically silenced during neoplastic development.
dine nucleotides in exon 1 while the mutant allele has an insertion of one
additional guanidine residue at this sequence. PCR primers flanking thisExperimental procedures
region were designed to yield an approximately 220 base pair product
(forward primer 5-TGGCTGGTCACCAGAGGGTG-3 and reverse primerCell culture, transfection, and screening for recombinants
5-GACCGTAACTATTCGGTGCG-3). The forward primer was labeled withHCT116 cells (American Type Culture Collection, Manassas, Virginia) were
fluoroscein at its 5 end by Gene Link (Hawthorne, New York). Cyclingcultured in McCoy’s 5A modified media supplemented with 10% fetal bovine
conditions using Platinum Taq (Invitrogen) were: 94C for 2 min followed byserum and 1% penicillin/streptomycin. DNMT1 and DNMT3B targeting was
30 cycles of 94C for 10 s, 58C for 15 s, and 68C for 30 s. The PCRperformed as previously described (Rhee et al., 2002). To target the p16INK4A
products were separated by capillary electrophoresis on a SpectruMedixlocus, HCT116 cells were transfected with the linearized p16INK4A targeting
9610 instrument fitted with 192 capillaries (State College, Pennsylvania).vectors described in Figure 3 using LipofectAmine (Invitrogen, Carlsbad,
Two peaks, representing the wt and mutant alleles, were observed in thisCalifornia) and selected in growth medium supplemented with 0.4 mg/ml
analysis when it was performed on control HCT116 samples. The resultsgeneticin (Invitrogen). General aspects of targeting with bipartite Neo vectors
obtained upon ChIP were confirmed by manual sequencing using 33P-labeledare described in Jallepalli et al. (2001). Homologous recombinants identified
ddNTPs and Thermosequenase (Amersham, Piscataway, New Jersey).by PCR were confirmed by genomic sequencing using one primer from the
Neo gene and another from the p16INK4A locus outside the targeting arms.
High performance liquid chromatographyEach TKO clone had a total of five targeted alleles; the targeting order was
Approximately 40 g of RNA-free genomic DNA, prepared using the BloodDNMT3B, allele 1 → DNMT3B, allele 2 → DNMT1, allele 1 → p16INK4A (wt or
and Cell Culture DNA Midi Kit (Qiagen, Valencia, California), was quantita-mutant allele) → DNMT1, allele 2. DKO and TKO clones were passaged by
tively digested with nuclease P1 (Roche Molecular Biochemicals, Indianapo-splitting 1:10 when the cells reached 90% confluency.
lis, Indiana) and calf intestinal alkaline phosphatase (Sigma) as described
(Kuo et al., 1980). Samples were separated on a reversed-phase columnIn vitro growth assays
(Supelcosil LC-18 DB, Sigma) at room temperature, monitoring absorbancesCells were seeded in triplicate in 12-well plates at a concentration of 3 
at 275 nm and 285 nm (Feinberg et al., 1988). Peak assignments were104 cells/well. Cells were harvested at days 2, 4, 6, and 8 for analysis, lysed
confirmed using deoxyribonucleoside standards (Sigma). 5-Methylcytosinein 0.6% Igepal CA-630 (Sigma, St. Louis, Missouri) and 0.4% PicoGreen
content was expressed as a percentage of the total cytosine pool, using(Molecular Probes, Eugene, Oregon), and incubated at room temperature
peak areas after correction for extinction coefficients.for 20 min. Fluorescence was measured using a Fluostar Galaxy (BMG,
Durham, North Carolina) plate reader with excitation at 485 nm and emission
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